Clinical Trials Directory

Trials / Unknown

UnknownNCT04622202

Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section

The Effects Of Pre-emptive Single Oral Dose Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
74 (estimated)
Sponsor
Zagazig University · Other Government
Sex
Female
Age
21 Years – 38 Years
Healthy volunteers
Accepted

Summary

There is exaggerated neuroendocrine stress response to laryngoscopy and endotracheal intubation during the Induction to anesthesia-delivery (I-D) period under light anesthesia. Mechanical stimulation of laryngeal proprioceptors elicits increased secretion of cortisol and catecholamine with subsequent elevation of blood pressure from 40 to 50 % and heart rate up to 20 % during direct laryngoscopy and endotracheal intubation

Detailed description

The sample size was calculated using OPEN EPI program assuming that the mean visual analogue scale anxiety score was 49.3±14.1 among oral pregabalin group and was 58.6± 14.4 among Placebo group (8) so at power of study 80% confidence interval 95%, the sample size was calculated to be 74 cases (37in each group

Conditions

Interventions

TypeNameDescription
DRUGPregabalin 150mgoral capsule pregabalin 150 mg.
DRUGmultivitaminoral placebo in the form of oral multivitamin capsule.

Timeline

Start date
2020-11-15
Primary completion
2021-02-28
Completion
2021-03-01
First posted
2020-11-09
Last updated
2021-02-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04622202. Inclusion in this directory is not an endorsement.

Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section (NCT04622202) · Clinical Trials Directory